Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
AstraZeneca
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Trabectedin - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for trabectedin and what is the scope of freedom to operate?

Trabectedin is the generic ingredient in one branded drug marketed by Janssen Prods and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Trabectedin has forty-three patent family members in thirty-five countries.

There are four drug master file entries for trabectedin. One supplier is listed for this compound.

Summary for trabectedin
International Patents:43
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 4
Suppliers / Packagers: 1
Bulk Api Vendors: 26
Clinical Trials: 81
Patent Applications: 12
DailyMed Link:trabectedin at DailyMed
Recent Clinical Trials for trabectedin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 1
Institut BergoniƩN/A
AGO Research GmbHPhase 3

See all trabectedin clinical trials

Pharmacology for trabectedin
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Synonyms for trabectedin
114899-77-3
87541-EP2298780A1
87541-EP2305689A1
AC-27767
AC1L33FK
AKOS025401985
AN-5365
C39H43N3O11S
CAS-114899-77-3
CCRIS 8133
CHEBI:84050
CHEMBL450449
CS-1608
DB05109
DSSTox_CID_26880
DSSTox_GSID_46880
DSSTox_RID_81984
DTXSID2046880
Ect 743
Ecteinascidin
ecteinascidin 743
Ecteinascidin 743;ET-743;Ecteinascidin
Ecteinascidin 743|||ET-743|||Yondelis|||NSC-684766
Ecteinascidine 743
Et 743
ET-743
ET743
GTPL2774
HY-50936
ID0YZQ2TCP
LS-146121
NCGC00181159-01
NCGC00181159-02
NSC 648766
NSC 684766
NSC-684766
PKVRCIRHQMSYJX-AIFWHQITSA-N
SCHEMBL12119916
Tox21_112762
Tox21_113236
Trabectedin [INN]
Trabectedin [USAN:INN:BAN]
UNII-ID0YZQ2TCP
X5006
Yondelis
Z-3121
ZINC150338708

US Patents and Regulatory Information for trabectedin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Prods YONDELIS trabectedin POWDER;INTRAVENOUS 207953-001 Oct 23, 2015 RX Yes Yes   See Pricing   See Pricing   See Pricing
Janssen Prods YONDELIS trabectedin POWDER;INTRAVENOUS 207953-001 Oct 23, 2015 RX Yes Yes   See Pricing   See Pricing   See Pricing
Janssen Prods YONDELIS trabectedin POWDER;INTRAVENOUS 207953-001 Oct 23, 2015 RX Yes Yes   See Pricing   See Pricing   See Pricing
Janssen Prods YONDELIS trabectedin POWDER;INTRAVENOUS 207953-001 Oct 23, 2015 RX Yes Yes   See Pricing   See Pricing   See Pricing
Janssen Prods YONDELIS trabectedin POWDER;INTRAVENOUS 207953-001 Oct 23, 2015 RX Yes Yes   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Harvard Business School
McKinsey
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.